Background Cardiogenic shock (CS) induced by severe aortic stenosis (AS) is a life-threatening condition with high mortality.

Aortic stenosis, affecting nine million people globally, is often unnoticed as symptoms are mistaken for aging. This heart ...

Aims Exercise testing remains underused in patients with aortic stenosis (AS), partly due to concerns about an ...

New 20-year data show a survival rate of 90% with few repeat surgeries after this complex operation that can only be ...

The Navitor Vision, Abbott's latest TAVI system, is designed to improve accuracy during implantation and enhance visibility ...

CABG plus surgical aortic valve replacement for treatment of coronary disease and aortic stenosis was associated with better 5-year outcomes vs. PCI plus transcatheter aortic valve replacement in ...

Our Bureau, Mumbai Thursday, January 30, 2025, 15:15 Hrs [IST] ...

Patients with low-gradient aortic stenosis and reduced LVEF, compared with patients with high-gradient aortic stenosis, have worse clinical outcomes.

GlobalData analysts anticipate FDA approval for the JenaValve Trilogy TAVR device designed to treat aortic regurgitation (AR) ...

Navitor Vision enhances visibility and precision in TAVI procedures, offering a less invasive alternative to surgical aortic ...

The US Food and Drugs Administration (FDA) is expected to approve the JenaValve Trilogy System, a transcatheter aortic valve ...